Neovasc Inc (US) (NASDAQ:NVCN) (TSE:NVC) is scheduled to release its earnings data after the market closes on Wednesday, March 28th.
Shares of Neovasc Inc (NASDAQ:NVCN) opened at $0.11 on Monday. The stock has a market cap of $8.69, a price-to-earnings ratio of 0.46 and a beta of 0.52. Neovasc Inc has a 12-month low of $0.10 and a 12-month high of $2.04.
Several research firms have issued reports on NVCN. ValuEngine lowered shares of Neovasc Inc (US) from a “sell” rating to a “strong sell” rating in a research report on Friday, December 1st. Zacks Investment Research lowered shares of Neovasc Inc (US) from a “hold” rating to a “sell” rating in a research report on Wednesday, January 31st. Finally, Canaccord Genuity restated a “buy” rating and issued a $1.05 price target on shares of Neovasc Inc (US) in a research report on Friday, January 19th. Two research analysts have rated the stock with a sell rating and three have given a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $2.95.
Neovasc Inc (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company’s segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products.
Receive News & Ratings for Neovasc Inc (US) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc Inc (US) and related companies with MarketBeat.com's FREE daily email newsletter.